Patanjali's defiance of advertising regulations sparks Supreme Court rebuke.

‘Despite warnings, Patanjali's misleading ads persist, raising concerns about consumer trust. #patanjali #medindia’






Patanjali: Defiance Amidst Warnings
The genesis of this legal confrontation stems from Patanjali's persistent flouting of regulations, particularly under the Drugs and Magic Remedies (Objectionable Advertisements) Act (DOMA). The Act expressly prohibits the advertisement of products claiming to treat specific diseases unless backed by scientific evidence. Despite these clear stipulations, Patanjali's advertisements have often made bold claims about the efficacy of its products in treating various ailments, disregarding the established norms.The Indian Medical Association (IMA) has been vocal in its criticism of Patanjali's advertising strategies, citing instances of false and unfounded claims about curing diseases. Moreover, Baba Ramdev's disparaging remarks about allopathic medicine, branding it as "stupid and bankrupt," have only added fuel to the fire. Such rhetoric not only undermines the credibility of established medical practices but also poses a significant risk to public health, especially in times of crisis such as the COVID-19 pandemic.
Upholding Ethical Advertising Practices
Despite regulatory frameworks in place, including the Memorandum of Understanding between the AYUSH ministry and the Advertising Standards Council of India, Patanjali has continued its misleading advertising campaigns with impunity. The company's non-compliance with regulatory guidelines raises questions about the efficacy of existing enforcement mechanisms and the commitment of regulatory bodies to uphold consumer protection standards.The Supreme Court's admonition serves as a wake-up call not only to Patanjali but also to regulatory authorities and the government. The court's skepticism about the efficacy of existing regulatory mechanisms underscores the urgent need for robust enforcement measures and greater accountability in the advertising industry.
Moreover, the court's emphasis on protecting public health highlights the responsibility of the government to safeguard citizens from deceptive marketing practices. With a significant portion of the population susceptible to misinformation, particularly in matters of health and wellness, the government must prioritize the enforcement of stringent regulations to prevent the exploitation of consumer trust.
In conclusion, the Supreme Court's rebuke of Patanjali Ayurved underscores the need for a comprehensive overhaul of regulatory frameworks governing advertising practices. As a prominent player in the market, Patanjali must recognize its social responsibility and adhere to ethical standards in its advertising endeavors. Failure to do so not only erodes public trust but also undermines the integrity of the healthcare system as a whole. It's time for Patanjali to heed the warnings and embrace responsible advertising practices in the interest of public health and consumer well-being.
Advertisement
Source-Medindia